BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20824145)

  • 1. The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol.
    Steensland P; Simms JA; Nielsen CK; Holgate J; Bito-Onon JJ; Bartlett SE
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans rats.
    Doherty JM; Gonzales RA
    Alcohol; 2015 Sep; 49(6):543-51. PubMed ID: 26142563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.
    Schank JR; Pickens CL; Rowe KE; Cheng K; Thorsell A; Rice KC; Shaham Y; Heilig M
    Psychopharmacology (Berl); 2011 Nov; 218(1):111-9. PubMed ID: 21340476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The galanin-3 receptor antagonist, SNAP 37889, suppresses alcohol drinking and morphine self-administration in mice.
    Scheller KJ; Williams SJ; Lawrence AJ; Djouma E
    Neuropharmacology; 2017 May; 118():1-12. PubMed ID: 28274821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites.
    Reed-Hagen AE; Tsuchiya M; Shimada K; Wentland JA; Obach RS
    Biopharm Drug Dispos; 1999 Dec; 20(9):429-39. PubMed ID: 10951432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tachykinin NK1 receptor antagonist attenuates the 4 beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat.
    Tsuchiya M; Sakakibara A; Yamamoto M
    Eur J Pharmacol; 2005 Jan; 507(1-3):29-34. PubMed ID: 15659291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
    Prakash C; O'Donnell J; Khojasteh-Bakht SC
    Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operant self-administration of sweetened ethanol and time course of blood ethanol levels in adolescent and adult male Long-Evans rats.
    Doherty JM; Gonzales RA
    Alcohol Clin Exp Res; 2015 Mar; 39(3):485-95. PubMed ID: 25702920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat.
    Windisch KA; Czachowski CL
    Alcohol; 2018 Feb; 66():77-85. PubMed ID: 29220747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone.
    Middaugh LD; Lee AM; Bandy AL
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1172-9. PubMed ID: 10968654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose- but not alcohol-responding in mice.
    Walker AW; Smith CM; Gundlach AL; Lawrence AJ
    Genes Brain Behav; 2015 Nov; 14(8):625-34. PubMed ID: 26278401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training.
    Augier E; Flanigan M; Dulman RS; Pincus A; Schank JR; Rice KC; Kejun C; Heilig M; Tapocik JD
    Psychopharmacology (Berl); 2014 Dec; 231(23):4561-8. PubMed ID: 24858375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.
    Rorick-Kehn LM; Ciccocioppo R; Wong CJ; Witkin JM; Martinez-Grau MA; Stopponi S; Adams BL; Katner JS; Perry KW; Toledo MA; Diaz N; Lafuente C; Jiménez A; Benito A; Pedregal C; Weiss F; Statnick MA
    Alcohol Clin Exp Res; 2016 May; 40(5):945-54. PubMed ID: 27084498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.
    Srisontiyakul J; Kastman HE; Krstew EV; Govitrapong P; Lawrence AJ
    Neurochem Res; 2016 Dec; 41(12):3206-3214. PubMed ID: 27573375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
    Obach RS
    Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice.
    Lopez MF; Moorman DE; Aston-Jones G; Becker HC
    Brain Res; 2016 Apr; 1636():74-80. PubMed ID: 26851547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking.
    Sabino V; Cottone P; Zhao Y; Iyer MR; Steardo L; Steardo L; Rice KC; Conti B; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2009 May; 34(6):1482-93. PubMed ID: 18946467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of mecamylamine on ethanol and sucrose self-administration.
    Ford MM; Fretwell AM; Nickel JD; Mark GP; Strong MN; Yoneyama N; Finn DA
    Neuropharmacology; 2009 Sep; 57(3):250-8. PubMed ID: 19501109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.